Former Chairman and CEO, Johnson & Johnson

Chairman of the Board and Chief Executive Officer

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants

Johnson &amp; Johnson price target raised by $21 at Bernstein, here's why

Prostate Cancer Hormone Therapy Market to Reach US$ 79.89 Bn by 2032, Reports Persistence Market Research

Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference

0.8571428656578064

Director, Marketing Engagement & Education, US Oncology

Johnson & Johnson is a leader in healthcare innovation, dedicated to developing treatments and solutions for complex diseases. The Director of Marketing Engagement & Education for US Oncology will lead the Marketing Engagements & Education Team, focusing on strategy and operational excellence in speaker bureaus, sponsorships, and fee-for-service contracting to support oncology initiatives.

VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Johnson & Johnson is a leader in healthcare innovation, committed to improving health outcomes. The Director of Marketing Engagement & Education for US Oncology will lead the Marketing Engagements & Education Team, focusing on strategy, operational excellence, and collaboration across various teams to enhance oncology marketing efforts.

Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center

Senior Vice President, Head Development Operations & Portfolio Management

Nation’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at the Prestigious Regeneron Science Talent Search

JPM26: Regeneron will not overpay in M&A deals amid lead asset patent expiries

Genetic Therapy Aims To Bring Hearing To Those Born Deaf

STAT+: Regeneron’s chief scientist on Trump’s drug pricing policy, gene therapy, and the problem with AI

0.5714285969734192

Senior Director, Oncology Marketing - US Skin Lead

Regeneron is a leading healthcare solutions company, and they are seeking a Senior Director for Oncology Marketing to lead the US Skin Marketing team. This role involves developing marketing strategies for Non-Melanoma Skin Cancer, managing a team, and collaborating with cross-functional partners to drive product performance and achieve business objectives.

Senior Director, Oncology Marketing - US Lung Lead

Regeneron is a leading biotechnology company, and they are seeking a Senior Director for US Lung Marketing within their Oncology Business Unit. This role involves leading the marketing efforts for the NSCLC indication in the US, managing a team, and ensuring alignment with global strategies and performance objectives.

SVP, Global Regulatory Sciences

Chief Commercial Officer

Clinical Trials Market Size to Reach USD 175.02 Billion by 2035

Sanofi linked to takeover bid for Ocular Therapeutix

Five Biggest Biopharma Takeovers of 2025

Sanofi’s Neuro Push Arrives in Seoul With $1B+ Alzheimer’s Play

Associate Director, US HCP Marketing, Medical Education

Blueprint Medicines is a global biopharmaceutical company focused on inventing life-changing medicines. The Associate Director, US HCP Marketing, Medical Education Lead will develop and execute strategic education initiatives to empower healthcare professionals in recognizing and treating systemic mastocytosis, while ensuring alignment with broader brand objectives.